Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma

By Avilés Agustin   Neri Natividad   Castañeda Claudia   Talavera Alejandra   Huerta-Guzmán Judith   González Martha  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 55-58

Humana Press, Inc

Access to resources Recommend Favorite

Ewing Sarcoma Arising After Treatment of Diffuse Large B-cell Lymphoma

By Hiramoto Nobuhiro   Kobayashi Yukio   Nomoto Junko   Maruyama Dai   Watanabe Takashi   Tochigi Naobumi   Furuta Koh   Takeda Ken   Chuman Hirokazu   Yagyu Shigeki   Hosoi Hajime   Tobinai Kensei  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 417-421

Oxford University Press

Access to resources Recommend Favorite

Aggressive primary testicular diffuse large B-cell lymphoma, not otherwise specified with expression of interferon-γ and its receptors

By Nakayama-Ichiyama Shoko   Yokote Taiji   Hirata Yuji   Iwaki Kazuki   Nishiwaki Uta   Miyoshi Takuji   Masuda Yuki   Akioka Toshikazu   Tsuji Motomu   Hanafusa Toshiaki  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 814-816

Informa Healthcare

Access to resources Recommend Favorite

Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome

By Sano Takeshi   Sakai Hisashi   Takimoto Kengo   Ohno Hitoshi  

International Journal of Clinical Oncology, Vol. 12, Iss. 1, 2007-02 ,pp. : 59-62

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 851-856

Spandidos Publications

Access to resources Recommend Favorite